trending Market Intelligence /marketintelligence/en/news-insights/trending/vgvsmowyxcf7enmcnh-72g2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Memphasys plans 1-for-15 share consolidation

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Memphasys plans 1-for-15 share consolidation

Memphasys Ltd.'s board plans to implement a 1-for-15 share consolidation to make its stock more manageable.

The consolidation will reduce the Australian company's issued share capital to about 340,588,613 ordinary shares from 5,108,829,192 ordinary shares.

Additionally, the number of issued options will be reduced to about 14,998,125 from 224,971,876, the provider of cell and protein separation devices said. The exercise price of these options will also increase by a factor of 15.

Shareholders will vote on the proposal at an Aug. 6 general meeting. Memphasys expects its stock to start trading on a post-consolidation basis Aug. 8.